Matt Delaney joined NBDF in 2022 as government relations manager, where he assists NBDF chapters in advocacy and policy, and contributes to the foundation’s federal and international work on blood and product safety and supply. As a person who lives…
Meet NHF's Chapter Development Specialist, Nick Kallinicou! Nick took his passion for meaningful and impactful work and joined NHF. He continues to be a vital part of the NHF community and assisting families and patients. Learn more about…
Amy L. Dunn. MD is a Professor of Pediatrics at Nationwide Children's Hospital, the Ohio State University College of Medicine where she is the Director of Pediatric Hematology and directs the Hemostasis Treatment Center. Dr Dunn received her medical…
FOR IMMEDIATE RELEASE
Abortion and contraception can both be critical components of an individual’s health care journey. However, it is important to not conflate abortion and birth control as one in the same – both are medical in…
Sanofi and Swedish Orphan Biovitrum AB (Sobi®) recently shared positive results from the XTEND-1 pivotal phase 3 study of efanesoctocog alfa (BIVV001).
BIVV001 is an investigational recombinant factor VIII therapy (rFVIII) developed for the…
The recent Congress of the International Society on Thrombosis and Haemostasis (ISTH) included some noteworthy findings on the rare blood disorders news front. Hemab Therapeutics, which specializes in developing therapies that target serious…
Sanofi recently shared new clinical trial updates for their investigational hemophilia therapy fitusiran. The Phase 3 ATLAS-PPX study is evaluating the efficacy and safety of fitusiran (80 mg) when administered prophylactically (once per month) to…
Markers of autoimmunity in immune thrombocytopenia
Speaker(s): Dr. Marie Hollenhorst
NHF's Wednesday Webinars are a free education series open to providers and community members. Register to attend and learn…
50 Years of the JGP Research Fellowship
Speaker(s): NHF Research Team
NHF's Wednesday Webinars are a free education series open to providers and community members. Register to attend and learn about the latest…